MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$46,245K
EPS
-$0.69
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
39,197
33,470
28,261*
25,469
General and administrative
9,806
8,528
7,907*
7,475
Total operating expenses
49,003
41,998
36,168
32,944
Loss from operations
-49,003
-41,998
-36,168*
-32,944
Interest and other income, net
3,445
2,693
3,170
3,076
Total other income
3,445
2,693
3,170*
3,076
Net loss
-45,558
-39,305
-32,998*
-29,868
Unrealized loss on marketable securities, net
-687
-286
-8*
6
Comprehensive loss
-46,245
-39,591
-33,006
-29,862
Basic EPS
-0.69
-0.64
-0.554
-0.5
Diluted EPS
-0.69
-0.64
-0.554
-0.5
Basic Average Shares
65,991,171
61,746,050
59,585,456
59,670,757
Diluted Average Shares
65,991,171
61,746,050
59,585,456
59,670,757
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$46,245K
(-63.12%↓ Y/Y)
Interest and other
income, net
$3,445K
(2.71%↑ Y/Y)
Net loss
-$45,558K
(-62.14%↓ Y/Y)
Unrealized loss on
marketable securities, net
-$687K
(-172.62%↓ Y/Y)
Total other income
$3,445K
(2.71%↑ Y/Y)
Loss from operations
-$49,003K
(-55.80%↓ Y/Y)
Total operating
expenses
$49,003K
(55.80%↑ Y/Y)
Research and development
$39,197K
(61.24%↑ Y/Y)
General and
administrative
$9,806K
(37.28%↑ Y/Y)
Buy us a coffee
Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc. (TYRA)